Novavax (NVAX) Initiates Phase 2b/3 Hummingbird Trial for COVID-19 Vaccine in Children Aged Six Months Through 11 Years

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Novavax (NVAX) Initiates Phase 2b/3 Hummingbird Trial for COVID-19 Vaccine in Children Aged Six Months Through 11 Years
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.00 --0 (-0%)
Previous Close $9.00    52 Week High $9.23 
Open $8.81    52 Week Low $1.16 
Day High $9.59    P/E N/A 
Day Low $8.81    EPS $-0.30 
Volume 4,235,734